About the campaign
The American Cancer Society has launched a state-wide campaign entitled: HPV Cancer Free Texas with a goal to increase vaccine uptake and completion rates in the state of Texas to 80 percent by 2026. This campaign consists of equipping hospital systems, federally qualified health centers, private providers, nurses and more with tools and resources to help increase uptake of the HPV vaccine.
The ongoing coronavirus 2019 (COVID-19) pandemic has created unprecedented challenges for healthcare providers, patients, and policymakers. One outcome from the past few months is dramatic declines in vaccination. A recent study showed that during this time a 71% drop in healthcare visits for 7-17-year-olds occurred, ages when critical vaccines like Tdap, HPV, and meningitis are given. These declines put children and communities at greater risk for outbreaks of vaccine-preventable diseases.
About the ECHO series
American Cancer Society’s free HPV Medical ECHO is focused on helping clinic teams, which may include private providers, nurses, medical assistants and more learn about best practices, team engagement, evidence-based strategies for recommending, delivering, and prioritizing the HPV vaccine and other vaccines amidst COVID-19.
ECHO is designed to learn through peer-to-peer clinical case studies and didactics taught by national leaders in HPV vaccination.
The ECHO consists of four sessions lasting one hour each:
May 27, 2021: HPV 101-Related Cancers and HPV Vaccination in Texas
June 10, 2021: Presumptive Communication Part 1
June 24, 2021: Presumptive Communication Part 2 and Vaccine Decision Making
July 8, 2021: Next Steps: Engaging the Team
Mission: HPV Cancer Free Texas Vaccination ECHO – Medical Clinic – Welcome PacketView More
Noel Brewer, PhD
Professor, Department of Health Behavior
Rachel Coughlin, MPH, CNPM
Senior Program Manager, HPV Cancer Free Texas
Marcie Fisher-Borne, PhD, MSW, MPH
Managing Director, Interventions & Implementation
Tralisa Hall, MEd
Program Manager, HPV Cancer Free Texas
Anna Hassan, MPH, PMP
Director, Clinical Interventions
Jason Terk, MD, FAAP